• Plexus Announces Fiscal First Quarter Financial Results

    来源: Nasdaq GlobeNewswire / 26 1月 2022 16:15:00   America/New_York

    NEENAH, WI, Jan. 26, 2022 (GLOBE NEWSWIRE) -- Plexus Corp. (NASDAQ: PLXS) today announced financial results for our fiscal first quarter ended January 1, 2022, and guidance for our fiscal second quarter ending April 2, 2022.

    • Reports fiscal first quarter revenue of $817 million, GAAP operating margin of 3.7% and GAAP diluted EPS of $0.82, including $0.22 of stock-based compensation expense and $0.06 of restructuring charges
    • Initiates fiscal second quarter revenue guidance of $820 to $860 million with GAAP diluted EPS of $0.76 to $0.92, including $0.23 of stock-based compensation expense
      Three Months Ended
      Jan 1, 2022 Jan 1, 2022 Apr 2, 2022
      Q1F22 Results
     Q1F22 Preliminary Results (3) Q2F22 Guidance
    Summary GAAP Items     
    Revenue (in millions)$817  $815 to $820 $820 to $860
    Operating margin 3.7%   3.6% to 4.0%
    Diluted EPS (1)$0.82  $0.80 to $0.84 $0.76 to $0.92
           
    Summary Non-GAAP Items (2)     
    Return on invested capital (ROIC) 10.0%    
    Economic return 0.7%    
           
    (1Includes stock-based compensation expense of $0.22 for Q1F22 results, $0.22 for Q1F22 preliminary results and $0.23 for Q2F22 guidance.
    (2Refer to Non-GAAP Supplemental Information in Tables 1 and 2 for non-GAAP financial measures and a reconciliation to GAAP.
    (3Preliminary results issued on January 18, 2022; guidance provided on October 27, 2021, was revenue of $825 to $865 million and GAAP diluted EPS of $1.01 to $1.17, including $0.21 of stock based compensation expense.
     

    Fiscal First Quarter 2022 Information

    • Won 41 manufacturing programs during the quarter representing $271 million in annualized revenue when fully ramped into production
    • Trailing four quarter manufacturing wins total $1.1 billion in annualized revenue when fully ramped into production
    • Purchased $10.2 million of our shares at an average price of $91.74 per share under our share repurchase program. $36.7 million of our current $50 million authorization remains available to repurchase shares.

    Todd Kelsey, CEO, commented, "Fiscal first quarter revenue of $817 million and GAAP diluted EPS of $0.82 were consistent with our preliminary results issued on January 18, 2022, which reflected the impact from unanticipated supply chain constraints in the Americas region that worsened in the final weeks of the quarter."

    Mr. Kelsey continued, "Strong manufacturing program win performance, a multi-year high in the value of engineering wins and expansion of an already robust funnel of qualified manufacturing opportunities represented notable successes in the fiscal first quarter. Our trailing four-quarter new manufacturing program wins expanded 7% year over year to a record of $1.1 billion. Additionally, our funnel of qualified manufacturing opportunities reached an all-time high of $3.3 billion. The significant quantity of new engineering engagements, expansion in our funnel of manufacturing opportunities and acceleration in our win rate positions us to sustain our program wins momentum and supports our long-term revenue growth goal.”

    Mr. Kelsey further commented, "We are guiding fiscal second quarter revenue of $820 to $860 million, which reflects the supply chain constraints that are again limiting our ability to meet robust customer demand. In addition, profitability will remain pressured given the operating infrastructure in place to support the strong customer forecasts and a seasonal increase in compensation costs. As such, we are guiding GAAP operating margin of 3.6% to 4.0% and GAAP EPS $0.76 to $0.92.”

    Mr. Kelsey concluded, "We are committed to delivering upon our goals of 9% to 12% annual revenue growth with 5.5% GAAP operating margin and 15% ROIC over the long-term. We anticipate sequential improvement in revenue and GAAP EPS through the remainder of fiscal 2022, supported by new program ramps, as we progress toward these goals.”

    Quarterly ComparisonThree Months Ended
    (in thousands, except EPS)Jan 1, 2022 Oct 2, 2021 Jan 2, 2021
    Revenue$817,456  $843,238  $830,355 
    Gross profit 69,996   78,967   79,277 
    Operating income 30,473   42,342   46,866 
    Net income 23,423   33,341   36,199 
    Diluted EPS$0.82  $1.16  $1.23 
          
    Gross margin 8.6%  9.4%  9.5%
    Operating margin 3.7%  5.0%  5.6%
          
    ROIC (1) 10.0%  15.4%  16.3%
    Economic return (1) 0.7%  7.3%  8.2%
          
    (1) Refer to Non-GAAP Supplemental Information in Tables 1 and 2 for non-GAAP financial measures discussed and/or disclosed in this release, such as adjusted operating margin, adjusted net income, adjusted diluted EPS, ROIC and economic return, and a reconciliation of these measures to their comparable GAAP measures.

    Business Segment and Market Sector Revenue

    Plexus measures operational performance and allocates resources on a geographic segment basis. Plexus also reports revenue based on the market sector breakout set forth in the table below, which reflects Plexus’ market sector focused strategy. Top 10 customers comprised 56% of revenue during both the first quarter of fiscal 2022 and the fourth quarter of fiscal 2021, up one percentage point from the first quarter of fiscal 2021 where the top 10 customers comprised 55% of revenue.

    Business Segments ($ in millions)Three Months Ended
     Jan 1, 2022 Oct 2, 2021 Jan 2, 2021
    Americas$277  $307  $327 
    Asia-Pacific 491   494   451 
    Europe, Middle East and Africa 73   74   79 
    Elimination of inter-segment sales (24)  (32)  (27)
    Total Revenue$817  $843  $830 
                


    Market Sectors ($ in millions)Three Months Ended
     Jan 1, 2022 Oct 2, 2021 Jan 2, 2021
    Industrial$36445% $39246% $37846%
    Healthcare/Life Sciences 34442%  33340%  31938%
    Aerospace/Defense 10913%  11814%  13316%
    Total Revenue$817  $843  $830 
             

    Non-GAAP Supplemental Information
    Plexus provides non-GAAP supplemental information, such as ROIC, economic return and free cash flow, because such measures are used for internal management goals and decision making, and because they provide management and investors with additional insight into financial performance. In addition, management uses these and other non-GAAP measures, such as adjusted operating income, adjusted operating margin, adjusted net income and adjusted diluted EPS, to provide a better understanding of core performance for purposes of period-to-period comparisons. Plexus believes that these measures are also useful to investors because they provide further insight by eliminating the effect of non-recurring items that are not reflective of continuing operations. For a full reconciliation of non-GAAP measures to comparable GAAP measures, please refer to the attached Non-GAAP Supplemental Information Tables.

    ROIC and Economic Return
    ROIC for the first quarter of fiscal 2022 was 10.0%. Plexus defines ROIC as tax-effected annualized adjusted operating income divided by average invested capital over a two-quarter period for the first fiscal quarter. Invested capital is defined as equity plus debt and operating lease obligations, less cash and cash equivalents. Plexus' weighted average cost of capital for fiscal 2022 is 9.3%. ROIC for the first quarter of fiscal 2022 less Plexus’ weighted average cost of capital resulted in an economic return of 0.7%.

    Free Cash Flow
    Plexus defines free cash flow as cash flows provided by operations less capital expenditures. For the three months ended January 1, 2022, cash flows used in operations was $89.0 million, less capital expenditures of $33.2 million, resulting in negative free cash flow of $122.2 million.

    Cash Cycle DaysThree Months Ended
     Jan 1, 2022 Oct 2, 2021 Jan 2, 2021
    Days in Accounts Receivable66  56  53 
    Days in Contract Assets12  13  12 
    Days in Inventory145  116  93 
    Days in Accounts Payable(87) (76) (59)
    Days in Cash Deposits(33) (24) (19)
    Annualized Cash Cycle *103  85  80 
    * We calculate cash cycle as the sum of days in accounts receivable, days in contract assets and days in inventory, less days in accounts payable and days in cash deposits.
     

    Conference Call and Webcast Information

    What:   Plexus Fiscal 2022 Q1 Earnings Conference Call and Webcast
    When:   Thursday, January 27, 2022 at 8:30 a.m. Eastern Time
    Where:   Participants are encouraged to join the live webcast at the investor relations section of the Plexus website, https://plexus.gcs-web.com/events-and-presentations/upcoming-events, where a slide presentation reviewing fiscal first quarter 2022 results will also be made available ahead of the conference call.

    Conference Call: +1.866.922.5180 with passcode: 3582506
    Replay:   The webcast will be archived on the Plexus website and available via telephone replay at +1.855.859.2056 or +1.404.537.3406 with passcode: 3582506

    Investor and Media Contact
    Shawn Harrison
    +1.920.969.6325
    shawn.harrison@plexus.com

    About Plexus
    Since 1979, Plexus has been partnering with companies to create the products that build a better world. We are a team of over 19,000 individuals who are dedicated to providing Design and Development, Supply Chain Solutions, New Product Introduction, Manufacturing and Aftermarket Services. Plexus is a global leader that specializes in serving customers in industries with highly complex products and demanding regulatory environments. Plexus delivers customer service excellence to leading companies by providing innovative, comprehensive solutions throughout a product’s lifecycle. For more information about Plexus, visit our website at www.plexus.com.

    Safe Harbor and Fair Disclosure Statement
    The statements contained in this press release that are guidance or which are not historical facts (such as statements in the future tense and statements including believe, expect, intend, plan, anticipate, goal, target and similar terms and concepts), including all discussions of periods which are not yet completed, are forward-looking statements that involve risks and uncertainties. These risks and uncertainties include the evolving effect, which may intensify, of COVID-19 on our employees, customers, suppliers, and logistics providers, including the impact of governmental actions being taken to curtail the spread of the virus. Other risks and uncertainties include, but are not limited to: the effect of inflationary pressures on our costs of production, profitability, and on the economic outlook of our markets; the effects of shortages and delays in obtaining components as a result of economic cycles, natural disasters or otherwise; the risk of customer delays, changes, cancellations or forecast inaccuracies in both ongoing and new programs; the lack of visibility of future orders, particularly in view of changing economic conditions; the economic performance of the industries, sectors and customers we serve; the effects of tariffs, trade disputes, trade agreements and other trade protection measures; the effects of the volume of revenue from certain sectors or programs on our margins in particular periods; our ability to secure new customers, maintain our current customer base and deliver product on a timely basis; the risks of concentration of work for certain customers; the particular risks relative to new or recent customers, programs or services, which risks include customer and other delays, start-up costs, potential inability to execute, the establishment of appropriate terms of agreements, and the lack of a track record of order volume and timing; the effects of start-up costs of new programs and facilities or the costs associated with the closure or consolidation of facilities; possible unexpected costs and operating disruption in transitioning programs, including transitions between Company facilities; the risk that new program wins and/or customer demand may not result in the expected revenue or profitability; the fact that customer orders may not lead to long-term relationships; our ability to manage successfully and execute a complex business model characterized by high product mix and demanding quality, regulatory, and other requirements; the risks associated with excess and obsolete inventory, including the risk that inventory purchased on behalf of our customers may not be consumed or otherwise paid for by the customer, resulting in an inventory write-off; risks related to information technology systems and data security; the ability to realize anticipated savings from restructuring or similar actions, as well as the adequacy of related charges as compared to actual expenses; increasing regulatory and compliance requirements; the effects of U.S. Tax Reform, any tax law changes as a result of change in U.S. presidential administration, and of related foreign jurisdiction tax developments; current or potential future barriers to the repatriation of funds that are currently held outside of the United States as a result of actions taken by other countries or otherwise; the potential effects of jurisdictional results on our taxes, tax rates, and our ability to use deferred tax assets and net operating losses; the weakness of areas of the global economy; the effect of changes in the pricing and margins of products; raw materials and component cost fluctuations; the potential effect of fluctuations in the value of the currencies in which we transact business; the effects of changes in economic conditions, political conditions and tax matters in the United States and in the other countries in which we do business (including as a result of the United Kingdom’s exit from the European Union); the potential effect of other world or local events or other events outside our control (such as changes in energy prices, terrorism, global health epidemics and weather events); the impact of increased competition; an inability to successfully manage human capital; changes in financial accounting standards; and other risks detailed herein and in our other Securities and Exchange Commission filings, particularly in Risk Factors contained in our fiscal 2021 Form 10-K and subsequently filed quarterly reports on Form 10-Q.

    PLEXUS CORP. AND SUBSIDIARIES
    CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
    (in thousands, except per share data)
    (unaudited)
      
     Three Months Ended
     Jan 1, Jan 2,
      2022   2021 
    Net sales$817,456  $830,355 
    Cost of sales 747,460   751,078 
    Gross profit 69,996   79,277 
    Operating expenses:   
    Selling and administrative expenses 37,502   32,411 
    Restructuring and impairment charges 2,021    
    Operating income 30,473   46,866 
    Other income (expense):   
    Interest expense (3,046)  (4,086)
    Interest income 271   374 
    Miscellaneous, net (923)  (1,518)
    Income before income taxes 26,775   41,636 
    Income tax expense 3,352   5,437 
    Net income$23,423  $36,199 
    Earnings per share:   
    Basic$0.84  $1.25 
    Diluted$0.82  $1.23 
    Weighted average shares outstanding:   
    Basic 28,018   28,861 
    Diluted 28,709   29,539 
            


    PLEXUS CORP. AND SUBSIDIARIES
    CONDENSED CONSOLIDATED BALANCE SHEETS
    (in thousands, except per share data)
    (unaudited)
        
      Jan 1,  Oct 2,
      2022   2021 
    ASSETS   
    Current assets:   
    Cash and cash equivalents$217,067  $270,172 
    Restricted cash 1,324   341 
    Accounts receivable 589,253   519,684 
    Contract assets 105,450   115,283 
    Inventories 1,185,915   972,312 
    Prepaid expenses and other 62,470   53,094 
    Total current assets 2,161,479   1,930,886 
    Property, plant and equipment, net 414,981   395,094 
    Operating lease right-of-use assets 69,519   72,087 
    Deferred income taxes 27,346   27,385 
    Other assets 36,321   36,441 
    Total non-current assets 548,167   531,007 
    Total assets$2,709,646  $2,461,893 
        
    LIABILITIES AND SHAREHOLDERS’ EQUITY   
    Current liabilities:   
    Current portion of long-term debt and finance lease obligations$151,417  $66,313 
    Accounts payable 711,248   634,969 
    Customer deposits 265,759   204,985 
    Accrued salaries and wages 57,221   75,394 
    Other accrued liabilities 180,840   147,042 
    Total current liabilities 1,366,485   1,128,703 
    Long-term debt and finance lease obligations, net of current portion 187,075   187,033 
    Accrued income taxes payable 47,974   47,974 
    Long-term operating lease liabilities 36,343   37,970 
    Deferred income taxes 5,307   5,677 
    Other liabilities 22,367   26,304 
    Total non-current liabilities 299,066   304,958 
    Total liabilities 1,665,551   1,433,661 
    Shareholders’ equity:   
    Common stock, $.01 par value, 200,000 shares authorized,   
    53,909 and 53,849 shares issued, respectively,   
    and 27,997 and 28,047 shares outstanding, respectively 539   538 
    Additional paid-in-capital 642,654   639,778 
    Common stock held in treasury, at cost, 25,912 and 25,802, respectively (1,053,222)  (1,043,091)
    Retained earnings 1,457,414   1,433,991 
    Accumulated other comprehensive loss (3,290)  (2,984)
    Total shareholders’ equity 1,044,095   1,028,232 
    Total liabilities and shareholders’ equity$2,709,646  $2,461,893 
        


    PLEXUS CORP. AND SUBSIDIARIES
    NON-GAAP SUPPLEMENTAL INFORMATION Table 1
    (in thousands, except per share data)
    (unaudited)
           
      Three Months Ended
      Jan 1, Oct 2, Jan 2,
      2022 2021 2021
    Operating income, as reported$30,473 $42,342 $46,866 
    Operating margin, as reported3.7
    %5.0
    %5.6
    %
           
    Non-GAAP adjustments:     
    Restructuring and impairment charges (1)2,021   
    Adjusted operating income$32,494 $42,342 $46,866 
    Adjusted operating margin4.0
    %5.0
    %5.6
    %
           
    Net income, as reported$23,423 $33,341 $36,199 
           
    Non-GAAP adjustments:     
    Restructuring and impairment charges, net of tax (1)1,809   
    Adjusted net income$25,232 $33,341 $36,199 
           
    Diluted earnings per share, as reported$0.82 $1.16 $1.23 
           
    Non-GAAP per share adjustments:     
    Restructuring and impairment charges, net of tax (1)0.06   
    Adjusted diluted earnings per share$0.88 $1.16 $1.23 
           
    (1) During the three months ended January 1, 2022, restructuring and impairment charges of $2.0 million, or $1.8 million net of taxes, were primarily incurred for employee severance costs associated with a facility transition in our Asia-Pacific region.
      


    PLEXUS CORP. AND SUBSIDIARIES
    NON-GAAP SUPPLEMENTAL INFORMATION Table 2
    (in thousands)
    (unaudited)
          
    ROIC and Economic Return Calculations Three Months Ended Twelve Months Ended Three Months Ended
     Jan 1, Oct 2, Jan 2,
     2022 2021 2021
    Operating income, as reported $30,473   $176,268   $46,866 
    Restructuring and impairment charges+ 2,021  + 3,267  +  
    Adjusted operating income $32,494   $179,535   $46,866 
     x 4     x 4 
             
             
    Adjusted annualized operating income $129,976   $179,535   $187,464 
    Adjusted effective tax ratex 13% x 13% x 13%
    Tax impact  16,897    23,340    24,370 
    Adjusted operating income (tax effected)  113,079   $156,195   $163,094 
             
    Average invested capital÷ 1,135,312  ÷$1,014,742  ÷$1,002,087 
             
    ROIC  10.0%   15.4%   16.3%
    Weighted average cost of capital- 9.3% - 8.1% - 8.1%
    Economic return  0.7%   7.3%   8.2%
                   


    Average Invested Capital CalculationsJan 1, Oct 2, Jul 3, Apr 3, Jan 2, Oct 3,
      2022   2021   2021   2021   2021   2020 
    Equity$1,044,095  $1,028,232  $1,020,450  $1,013,952  $1,006,959  $977,480 
    Plus:           
    Debt and finance lease obligations - current 151,417   66,313   60,468   50,229   148,408   146,829 
    Operating lease obligations - current (1) 9,507   9,877   9,130   9,314   9,351   7,724 
    Debt and finance lease obligations - long-term 187,075   187,033   187,690   188,730   188,148   187,975 
    Operating lease obligations - long-term 36,343   37,970   33,193   34,751   37,052   36,779 
    Less:           
    Cash and cash equivalents (217,067)  (270,172)  (303,255)  (294,370)  (356,724)  (385,807)
     $1,211,370  $1,059,253  $1,007,676  $1,002,606  $1,033,194  $970,980 
     
    (1Included in other accrued liabilities on the Condensed Consolidated Balance Sheets

    Primary Logo

分享